BlackRock Investment Management’s Factset FDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$22.4M Buy
137,178
+22,071
+19% +$3.52M 0.03% 615
2016
Q3
$18.7M Sell
115,107
-1,651
-1% -$285K 0.02% 630
2016
Q2
$18.8M Buy
116,758
+2,117
+2% +$327K 0.02% 603
2016
Q1
$17.4M Sell
114,641
-3,020
-3% -$450K 0.02% 640
2015
Q4
$19.1M Buy
117,661
+225
+0.2% +$37.8K 0.02% 596
2015
Q3
$18.8M Buy
117,436
+3,714
+3% +$608K 0.03% 588
2015
Q2
$18.5M Buy
113,722
+7,312
+7% +$1.19M 0.02% 622
2015
Q1
$16.9M Buy
106,410
+238
+0.2% +$35.7K 0.02% 650
2014
Q4
$14.9M Sell
106,172
-1,878
-2% -$249K 0.02% 691
2014
Q3
$13.1M Sell
108,050
-514
-0.5% -$63.5K 0.02% 754
2014
Q2
$13.1M Sell
108,564
-2,516
-2% -$273K 0.02% 785
2014
Q1
$12M Sell
111,080
-2,270
-2% -$240K 0.02% 817
2013
Q4
$12.3M Sell
113,350
-1,624
-1% -$180K 0.02% 763
2013
Q3
$12.5M Buy
114,974
+10,538
+10% +$1.14M 0.02% 692
2013
Q2
$10.6M Buy
+104,436
New +$10M 0.02% 708

Other funds holding FDS

BlackRock Investment Management's FDS Position: Q4 2016 in Review

BlackRock Investment Management increased its Factset (FDS) stake by 19% in Q4 2016, buying an estimated $3.52M and bringing the position to 137,178 shares worth $22.4M. The position accounts for 0.03% of the portfolio, ranked #615.

BlackRock Investment Management first reported a position in FDS in Q2 2013 and has held it in 15 quarters since. 389 funds tracked by Wall St. Rank hold FDS as of Q4 2016.

  • BlackRock Investment Management held 137,178 shares of Factset worth $22.4M as of Q4 2016.
  • BlackRock Investment Management bought 22,071 Factset shares in Q4 2016, an estimated $3.52M.
  • Factset made up 0.03% of BlackRock Investment Management's portfolio in Q4 2016, its #615 holding.
  • BlackRock Investment Management first reported a position in Factset in Q2 2013 and has held it in 15 quarters since.
  • 389 funds tracked by Wall St. Rank held Factset as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.